Tenet Healthcare Corp THC
We take great care to ensure that the data presented and summarized in this overview for TENET HEALTHCARE CORP is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding THC
View all-
Vanguard Group Inc Valley Forge, PA10.1MShares$1.36 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY9.88MShares$1.33 Billion0.03% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD7.13MShares$960 Million0.1% of portfolio
-
Invesco Ltd. Atlanta, GA5.01MShares$674 Million0.12% of portfolio
-
Pacer Advisors, Inc. Malvern, PA3.83MShares$516 Million1.19% of portfolio
-
State Street Corp Boston, MA2.99MShares$402 Million0.02% of portfolio
-
Glenview Capital Management, LLC New York, NY2.84MShares$382 Million9.06% of portfolio
-
Geode Capital Management, LLC Boston, MA2.12MShares$285 Million0.02% of portfolio
-
Arrowstreet Capital, Limited Partnership Boston, MA1.77MShares$239 Million0.18% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL1.56MShares$210 Million0.06% of portfolio
Latest Institutional Activity in THC
Top Purchases
Top Sells
About THC
Tenet Healthcare Corporation operates as a diversified healthcare services company. The company operates in three segments: Hospital Operations and Other, Ambulatory Care, and Conifer. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and coronary care units; cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics services; outpatient services, including physical therapy; cardiothoracic surgery, complex spinal surgery, neonatal intensive care, and neurosurgery services; quaternary care services in heart and kidney transplants; and limb-salvaging vascular procedure, acute level 1 trauma, intravascular stroke care, minimally invasive cardiac valve replacement, imaging, and telemedicine access services. In addition, it operates ambulatory surgery and urgent care centers, imaging centers, surgical hospitals, off-campus emergency departments, and micro-hospitals; and offers healthcare business process services in the areas of hospital and physician revenue cycle management, patient communications and engagement support, and value-based care solutions to hospitals, health systems, physician practices, employers, and other customers. As of February 09, 2022, the company operated 60 hospitals; and approximately 550 other healthcare facilities, including surgical hospitals, ambulatory surgery centers, urgent care and imaging centers, and other care sites and clinics. Tenet Healthcare Corporation was incorporated in 1975 and is headquartered in Dallas, Texas.
Insider Transactions at THC
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Feb 21
2025
|
Thomas W Arnst EVP, Chief Admin. Officer & GC |
SELL
Payment of exercise price or tax liability
|
Direct |
10,465
-18.65%
|
$1,349,985
$129.6 P/Share
|
Feb 21
2025
|
Thomas W Arnst EVP, Chief Admin. Officer & GC |
BUY
Exercise of conversion of derivative security
|
Direct |
4,214
+12.51%
|
-
|
Feb 21
2025
|
R. Scott Ramsey Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,836
-6.82%
|
$236,844
$129.6 P/Share
|
Feb 21
2025
|
R. Scott Ramsey Principal Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,054
+7.15%
|
-
|
Feb 21
2025
|
Saumya Sutaria CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
77,831
-9.51%
|
$10,040,199
$129.6 P/Share
|
Feb 21
2025
|
Saumya Sutaria CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
21,066
+4.79%
|
-
|
Feb 21
2025
|
Paola M Arbour EVP, Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,675
-6.59%
|
$603,075
$129.6 P/Share
|
Feb 21
2025
|
Paola M Arbour EVP, Chief Information Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,107
+5.51%
|
-
|
Feb 21
2025
|
Lisa Y Foo EVP, Commercial Ops |
SELL
Payment of exercise price or tax liability
|
Direct |
5,997
-10.18%
|
$773,613
$129.6 P/Share
|
Feb 21
2025
|
Lisa Y Foo EVP, Commercial Ops |
BUY
Exercise of conversion of derivative security
|
Direct |
2,107
+6.5%
|
-
|
Feb 11
2025
|
Lisa Y Foo EVP, Commercial Ops |
BUY
Grant, award, or other acquisition
|
Direct |
12,622
+30.93%
|
-
|
Feb 11
2025
|
Paola M Arbour EVP, Chief Information Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,622
+27.05%
|
-
|
Feb 11
2025
|
Saumya Sutaria CEO |
BUY
Grant, award, or other acquisition
|
Direct |
126,203
+24.09%
|
-
|
Feb 11
2025
|
Thomas W Arnst EVP, Chief Admin. Officer & GC |
BUY
Grant, award, or other acquisition
|
Direct |
25,244
+50.0%
|
-
|
Feb 11
2025
|
R. Scott Ramsey Principal Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,311
+33.31%
|
-
|
Oct 31
2024
|
Lisa Y Foo EVP, Commercial Ops |
SELL
Open market or private sale
|
Direct |
4,000
-10.5%
|
$620,000
$155.88 P/Share
|
Sep 05
2024
|
R. Scott Ramsey Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
11,599
-64.72%
|
$1,879,038
$162.06 P/Share
|
Aug 27
2024
|
Richard W Fisher |
SELL
Open market or private sale
|
Direct |
2,000
-6.36%
|
$326,000
$163.72 P/Share
|
Aug 16
2024
|
Paola M Arbour EVP, Chief Information Officer |
SELL
Open market or private sale
|
Direct |
8,377
-28.11%
|
$1,306,812
$156.0 P/Share
|
Aug 15
2024
|
Saumya Sutaria CEO |
SELL
Open market or private sale
|
Indirect |
13,773
-94.44%
|
$2,121,042
$154.93 P/Share
|
Last 12 Months Summary
Bona fide gift | 110K shares |
---|---|
Grant, award, or other acquisition | 183K shares |
Exercise of conversion of derivative security | 80.9K shares |
Open market or private sale | 244K shares |
---|---|
Bona fide gift | 235K shares |
Payment of exercise price or tax liability | 125K shares |